- The Gorman-Rupp Company recently reported past fourth-quarter revenue of US$166.6 million, surpassing expectations and contributing to record annual sales, adjusted earnings, and incoming orders, supported by a backlog of US$244 million.
- An interesting aspect for investors is the combination of this resilient order growth with a 53-year dividend increase streak, underscoring consistent cash generation and disciplined financial management.
- We’ll now examine how this record order momentum and healthy backlog shape Gorman-Rupp’s investment narrative for the period ahead.
AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
What Is Gorman-Rupp's Investment Narrative?
To own Gorman-Rupp, you need to be comfortable with a steady industrial story: durable pump demand across municipal and industrial markets, modest growth, and a management team that prioritizes balance sheet discipline and dividends over aggressive expansion. The latest quarter reinforces that picture rather than changing it. Record sales, earnings, and incoming orders, backed by a US$244 million backlog and roughly 11% order growth in the first nine months of 2025, support the near-term catalyst of solid earnings progression and cash generation. With the share price already strong and the valuation above some fair value estimates, the bigger question is whether that backlog can translate into profitable growth while the company carries a high debt load and operates with only mid-teens returns on equity.
However, investors should also be aware of how that high debt level could limit flexibility. Gorman-Rupp's share price has been on the slide but might be dropping deeper into value territory. Find out whether it's a bargain at this price.Exploring Other Perspectives
Four fair value estimates from the Simply Wall St Community span roughly US$28.56 to US$67.50, showing how far apart individual views can be. When you set that against Gorman-Rupp’s rich valuation and reliance on a strong backlog converting to earnings, it underlines why many market participants are weighing balance sheet risk alongside the company’s recent operational momentum.
Explore 4 other fair value estimates on Gorman-Rupp - why the stock might be worth as much as 6% more than the current price!
The Verdict Is Yours
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Gorman-Rupp research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Gorman-Rupp research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Gorman-Rupp's overall financial health at a glance.
Ready To Venture Into Other Investment Styles?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- This technology could replace computers: discover 22 stocks that are working to make quantum computing a reality.
- Find 50 companies with promising cash flow potential yet trading below their fair value.
- Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com